Pharma-Bio Serv (PBSV) Cash from Investing Activities Growth (1y) (2011 - 2026)
Powered by 
Analysis
Pharma-Bio Serv (PBSV) Cash from Investing Activities Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Accenture | 124.62 Bn | 115.58 Bn | 6.13 Bn | -164.86% |
| 2 | UL Solutions | 14.92 Bn | 14.51 Bn | 417.00 Mn | 329.82% |
| 3 | Gartner | 11.76 Bn | 10.28 Bn | 1.19 Bn | 45.04% |
| 4 | Tetra Tech | 9.19 Bn | 8.96 Bn | 243.21 Mn | 78.35% |
| 5 | Booz Allen Hamilton Holding | 8.76 Bn | 8.22 Bn | 1.46 Bn | -925.00% |
| 6 | Genpact | 6.27 Bn | 5.75 Bn | 490.34 Mn | 414.85% |
| 7 | Korn Ferry | 4.28 Bn | 3.15 Bn | 685.99 Mn | -95.42% |
| 8 | Fti Consulting | 4.20 Bn | 4.04 Bn | 316.27 Mn | -206.27% |
| 9 | Grand Canyon Education | 4.01 Bn | 3.73 Bn | 204.08 Mn | 243.96% |
| 10 | Pharma-Bio Serv | 12.37 Mn | 3.89 Mn | 902,041.00 | 41.52% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | 41.52% |
| Jan 31, 2026 | 179.94% |
| Oct 31, 2025 | -599.42% |
| Jul 31, 2025 | -55.86% |
| Apr 30, 2025 | -603.10% |
| Jan 31, 2025 | 120.75% |
| Oct 31, 2024 | -97.66% |
| Jul 31, 2024 | 159.75% |
| Apr 30, 2024 | -116.19% |
| Jan 31, 2024 | 41.94% |
| Oct 31, 2023 | 60,469.54% |
| Jul 31, 2023 | -295,829.66% |
| Apr 30, 2023 | 65,099.47% |
| Jan 31, 2023 | -1,199,309.94% |
| Oct 31, 2022 | -1,477.64% |
| Jul 31, 2022 | 70.65% |
| Apr 30, 2022 | -107.85% |
| Jan 31, 2022 | -100.05% |
| Oct 31, 2021 | 113.94% |
| Jul 31, 2021 | -267.77% |